Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2012
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science, Inc., World AIDS Institute and Timothy Ray Brown Foundation Hold Special Event Tomorrow, December 15, in Las Vegas: 'All I Want For Christmas is a Cure'
14-12-12
Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board
26-11-12
Cannabis Science, Inc. Appoints Harvard Law School Graduate Chad S. Johnson, Esq. as a Member of the Company's Board of Directors and as General Counsel
13-11-12
Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Science's Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
12-11-12
Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
09-11-12
NBC News Reports History Being Made as Legalization For Colorado and Washington State Optimistically Impacts Growth For Cannabis Science's New Drug Development Programs and State-by-State Medicinal Initiatives
07-11-12
Cannabis Science Appoints Christopher Meenan MS, MBA as Executive Vice President of Product Research and Development
02-11-12
Cannabis Science is Encouraged by ASA's Challenge; the Appeals Court Hears Case on Rescheduling of the Case on the Medicinal Value of Cannabinoids
18-10-13
Cannabis Science and World AIDS Institute Announce Appointment of Dr. Robert Melamede to Scientific Advisory Board
10-10-12
Cannabis Science Initiates Preclinical Investigation of CS-TATI-1 for European Studies for Squamous/Basal Cell Carcinomas and Kaposi’s Sarcoma
24-09-12